[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

CVS Corp (CVS)

CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs

Eli Lilly (LLY) stock extended gains on Wednesday after the pharmaceutical behemoth announced a new direct-to-consumer (DTC) collaboration with CVS Health (CVS). 

The press release said this team-up aims to improve patient access, affordability, and pharmacy support for Eli Lilly's blockbuster weight-loss treatments, Zepbound and Foundayo. 

Fundamentals

See More
  • Market Capitalization, $K 126,469,888
  • Shares Outstanding, K 1,275,927
  • Annual Sales, $ 402,067 M
  • Annual Income, $ 1,768 M
  • EBIT $ 11,691 M
  • EBITDA $ 22,022 M
  • 60-Month Beta 0.61
  • Price/Sales 0.33
  • Price/Cash Flow 7.08
  • Price/Book 1.73

Options Overview Details

View History
  • Implied Volatility 29.96% (+0.34%)
  • Historical Volatility 28.00%
  • IV Percentile 37%
  • IV Rank 30.65%
  • IV High 45.56% on 03/27/26
  • IV Low 23.07% on 08/28/25
  • Expected Move (DTE 1) 1.65 (1.69%)
  • Put/Call Vol Ratio 0.62
  • Today's Volume 5,305
  • Volume Avg (30-Day) 22,364
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 355,047
  • Open Int (30-Day) 340,177
  • Expected Range 95.73 to 99.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.70
  • Number of Estimates 9
  • High Estimate $1.80
  • Low Estimate $1.54
  • Prior Year $1.60
  • Growth Rate Est. (year over year) +6.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.50 +3.51%
on 08/05/26
110.68 -12.56%
on 07/22/26
-5.30 (-5.19%)
since 07/06/26
3-Month
86.22 +12.25%
on 05/07/26
110.68 -12.56%
on 07/22/26
+9.92 (+11.42%)
since 05/06/26
52-Week
62.55 +54.72%
on 08/07/25
110.68 -12.56%
on 07/22/26
+33.26 (+52.36%)
since 08/06/25

Most Recent Stories

More News
LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs

Eli Lilly shares rally on a fresh DTC partnership with CVS Health. A strong Q2 release and impressive future guidance is driving LLY stock higher as well.

CVS : 97.04 (-2.10%)
LLY : 1,178.60 (+0.75%)
CVS Health (NYSE:CVS) Reports Bullish Q2 CY2026

CVS Health (NYSE:CVS) Reports Bullish Q2 CY2026

CVS : 97.04 (-2.10%)
CVS Health: Q2 Earnings Snapshot

CVS Health: Q2 Earnings Snapshot

CVS : 97.04 (-2.10%)
CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

WOONSOCKET, R.I. , Aug. 5, 2026 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2026.

CVS : 97.04 (-2.10%)
CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications

WOONSOCKET, R.I. , Aug. 5, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced a revamp of its weight management program, making it easier for eligible adults to access clinical care, navigate...

CVS : 97.04 (-2.10%)
CVS Health's Turnaround Momentum May Not Survive Contact With Healthcare Cost Reality

Barchart Research What to Expect from CVS Earnings CVS Generated August 4, 2026 Current Price $104.42 EPS Estimate $$1.87 Consensus Rating Strong Buy Average Move 5.45% CVS Health's Turnaround Momentum...

CVS : 97.04 (-2.10%)
CVS Health earns two Gold and one Silver Stevie® Awards for Great Employers

AI Learning Academy honored for building enterprise-wide AI literacy and colleague confidence

CVS : 97.04 (-2.10%)
CVS Health (CVS) Q2 Earnings: What To Expect

CVS Health (CVS) Q2 Earnings: What To Expect

CVS : 97.04 (-2.10%)
CVS Health® named Overall Winner and wins four gold awards at 2026 US Customer Experience Awards

The enterprise earned the program's top honor plus gold recognition in AI innovation, measurement excellence, employee engagement, and consumer-centric culture

CVS : 97.04 (-2.10%)
UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal

UnitedHealth Group's Q2 2026 results show improved margins, a lower medical cost ratio, and raised earnings guidance, signaling its turnaround from 2025's steep stock decline is gaining traction.

CVS : 97.04 (-2.10%)
HUM : 358.70 (-1.41%)
CI : 271.33 (+0.31%)
UNH : 406.76 (-1.45%)
ELV : 389.90 (-0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed...

See More

Key Turning Points

3rd Resistance Point 109.00
2nd Resistance Point 104.77
1st Resistance Point 101.95
Last Price 97.04
1st Support Level 94.90
2nd Support Level 90.67
3rd Support Level 87.85

See More

52-Week High 110.68
Last Price 97.04
Fibonacci 61.8% 92.29
Fibonacci 50% 86.61
Fibonacci 38.2% 80.94
52-Week Low 62.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.